{"id":"cinametic-acid","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Cholagogues and Choleretics","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"transoddi","offLabel":[],"synonyms":["cinametic acid","transoddi"],"timeline":[],"approvals":[],"brandName":"Transoddi","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a complex orchestra, with many different instruments working together to create a beautiful symphony. Transoddi is like a new instrument that is being introduced into the orchestra, but we don't know exactly how it will fit in or what it will sound like. As it interacts with the other instruments, it may help to create a more harmonious and balanced sound, but we need more research to understand how it works.","oneSentence":"Transoddi is thought to work by interacting with specific biological pathways, but the exact mechanism is unknown.","technicalDetail":"Transoddi's mechanism of action is likely to involve the modulation of specific protein-protein interactions or the binding to specific receptors, but the exact molecular details are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/649","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CINAMETIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:01:59.605707","biosimilars":[],"competitors":[],"genericName":"cinametic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005794","UNII":"3E3106052Y","CHEBI":"CHEBI:134967","INN_ID":"3035","RXNORM":"21113","UMLSCUI":"C0055735","ChEMBL_ID":"CHEMBL2104040","PUBCHEM_CID":"6436159","MESH_SUPPLEMENTAL_RECORD_UI":"C007066"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Transoddi, also known as Cinamic Acid, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to determine its safety and efficacy. The lack of information on its pharmacokinetics and pharmacodynamics makes it difficult to assess its potential as a therapeutic agent.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}